Adam David Cohen (Adam Cohen, Adam D Cohen)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 30

Top Topics

Multiple Myeloma

Prognostic Factors

Top Venues

Nature medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Zainul Shoyeb Hasanali, Alfred L Garfall, Lisa Burzenski, Leonard D Shultz, Yan Tang, Siddhant Kadu, Neil C Sheppard, Derek Dopkin, Dan T Vogl, Adam David Cohen, Adam J Waxman, Sandra P Susanibar-Adaniya, Martin P Carroll, Edward A Stadtmauer, David Allman
Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice. bioRxiv : the preprint server for biology (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine 30 (4) (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine 30 (4) (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine 30 (4) (2024)
Zainul Shoyeb Hasanali, Alfred L Garfall, Lisa Burzenski, Leonard D Shultz, Yan Tang, Siddhant Kadu, Neil C Sheppard, Derek Dopkin, Dan T Vogl, Adam David Cohen, Adam J Waxman, Sandra P Susanibar-Adaniya, Martin P Carroll, Edward A Stadtmauer, David Allman
Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice. bioRxiv : the preprint server for biology (2024)
Zainul Shoyeb Hasanali, Alfred L Garfall, Lisa Burzenski, Leonard D Shultz, Yan Tang, Siddhant Kadu, Neil C Sheppard, Derek Dopkin, Dan T Vogl, Adam David Cohen, Adam J Waxman, Sandra P Susanibar-Adaniya, Martin P Carroll, Edward A Stadtmauer, David Allman
Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice. bioRxiv : the preprint server for biology (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T-cell Lymphoma and Secondary Primary Malignancy Risk After Commercial CAR T-cell Therapy. Nature medicine (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine 30 (4) (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine (2024)
Yan Tang, Wei Liu, Siddhant Kadu, Omar Johnson, Zainul Shoyeb Hasanali, Andre R Kelly, Alexander A Shestov, Eli Greenblat, Matthew Holmes, Li-Ping Wang, Natalie Shih, Roddy S O'Connor, Alfred L Garfall, David Allman, Dan T Vogl, Adam David Cohen, Carl H June, Neil C Sheppard
Exploiting the CD200-CD200R Immune Checkpoint Axis in Multiple Myeloma to Enhance CAR-T Therapy. Blood (2023)
Morie A Gertz, Adam David Cohen, Raymond L Comenzo, Efstathios Kastritis, Heather J Landau, Edward N Libby, Michaela Liedtke, Vaishali Sanchorawala, Stefan Schönland, Ashutosh D Wechalekar, Jeffrey A Zonder, Giovanni Palladini, Jackie Walling, Spencer Guthrie, Christie Nie, Carol Karp, Yuying Jin, Gene G Kinney, Giampaolo Merlini
Birtamimab plus standard of care in light chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial. Blood (2023)
Adam David Cohen, Samir Parekh, Bianca D Santomasso, Jaime Gállego Pérez-Larraya, Niels W C J van de Donk, Bertrand Arnulf, Maria-Victoria Mateos-Manteca, Nikoletta Lendvai, Carolyn C Jackson, Kevin C De Braganca, Jordan M Schecter, Loreta Marquez, Erin Lee, Ingrid Cornax, Enrique Zudaire, Claire Li, Yunsi Olyslager, Deepu Madduri, Helen Varsos, Lida Pacaud, Muhammad Akram, Dong Geng, Andrzej J Jakubowiak, Hermann Einsele, Sundar Jagannath
Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies. Blood cancer journal 12 (2) (2022)
Thomas Martin, Saad Z Usmani, Jesus G Berdeja, Mounzer Agha, Adam David Cohen, Parameswaran N Hari, David Avigan, Abhinav Deol, Myo Htut, Alexander Lesokhin, Nikhil C Munshi, Elizabeth O'Donnell, A Keith Stewart, Jordan M Schecter, Jenna D Goldberg, Carolyn C Jackson, Tzu-Min Yeh, Arnob Banerjee, Alicia Allred, Enrique Zudaire, William Deraedt, Yunsi Olyslager, Changwei Zhou, Lida Pacaud, Deepu Madduri, Andrzej J Jakubowiak, Yi Lin, Sundar Jagannath
Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Sandra P Susanibar-Adaniya, Edward A Stadtmauer, Adam David Cohen
CAR T cell therapy for multiple myeloma: What have we learned? Leukemia 36 (6) (2022)
Adam David Cohen, Maria-Victoria Mateos-Manteca, Yael C Cohen, Paula Rodriguez Otero, Juan José Lahuerta, Niels W C J van de Donk, Thomas G Martin, Attaya Suvannasankha, Kevin C De Braganca, Christina Corsale, Jordan M Schecter, Helen Varsos, William Deraedt, Liwei Wang, Martin Vogel, Tito Roccia, Xiaoying Xu, Pankaj Mistry, Enrique Zudaire, Muhammad Akram, Tonia Nesheiwat, Lida Pacaud, Irit Avivi, Jesús San F Miguel
Efficacy and safety of cilta-cel in patients with progressive MM after exposure to other BCMA-targeting agents. Blood (2022)
Alfred L Garfall, Adam David Cohen, Sandra P Susanibar-Adaniya, Wei-Ting Hwang, Dan T Vogl, Adam J Waxman, Simon F Lacey, Vanessa E Gonzalez, Joseph A Fraietta, Minnal Gupta, Irina Kulikovskaya, Lifeng Tian, Fang Chen, Natalka Koterba, Robert L Bartoszek, Margaret Patchin, Rong Xu, Gabriela Plesa, Donald L Siegel, Andrea Brennan, Anne Marie Nelson, Regina Ferthio, Angela Cosey, Kim-Marie Shea, Rachel Leskowitz, Megan Four, Wesley V Wilson, Fei Miao, Eric Lancaster, Beatriz M Carreno, Gerald P Linette, Elizabeth O Hexner, Regina M Young, Dexiu Bu, Keith G Mansfield, Jennifer L Brogdon, Carl H June, Michael C Milone, Edward A Stadtmauer
Anti-BCMA/CD19 CAR T cells with early immunomodulatory maintenance for multiple myeloma responding to initial or later-line therapy. Blood cancer discovery (2022)
Kavita M Dhodapkar, Adam David Cohen, Akhilesh Kaushal, Alfred L Garfall, Renee Julia Manalo, Allison R Carr, Samuel S McCachren, Edward A Stadtmauer, Simon F Lacey, Jan Joseph Melenhorst, Carl H June, Michael C Milone, Madhav V Dhodapkar
Changes in Bone Marrow Tumor and Immune Cells Correlate with Durability of Remissions Following BCMA CAR T Therapy in Myeloma. Blood cancer discovery 3 (6) (2022)
Luca Bernabei, Lifeng Tian, Alfred L Garfall, J Joseph Melenhorst, Simon F Lacey, Edward A Stadtmauer, Dan T Vogl, Vanessa E Gonzalez, Gabriela Plesa, Regina M Young, Adam Waxman, Bruce L Levine, Carl H June, Michael C Milone, Adam David Cohen
B-cell maturation antigen chimeric antigen receptor T-cell re-expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor-based combination therapy. British journal of haematology 193 (4) (2021)
Alfred L Garfall, Adam David Cohen, Edward Stadtmauer, Sandra P Susanibar-Adaniya, Dan T Vogl, Adam J Waxman
Overall Survival Remains Important in Trials of Early-Line Multiple Myeloma Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Muzaffar H Qazilbash, Neeraj Y Saini, Cha Soung-Chul, Zhe Wang, Edward Stadtmauer, Veerabhadran Baladandayuthapani, Heather Lin, Beryl Tross, Medhavi Honhar, Sheetal S Rao, Kunhwa Kim, Michael Popescu, Szymon Jakub Szymura, Tiantian Zhang, Aaron J Anderson, Qaiser Bashir, Elizabeth J Shpall, Robert Z Orlowski, Bruce L Levine, Naseem Kerr, Alfred L Garfall, Adam David Cohen, Dan T Vogl, Karen Dengel, Carl H June, Richard E Champlin, Larry W Kwak
A Randomized Phase II Trial of Idiotype Vaccination and Adoptive Autologous T-Cell Transfer in Multiple Myeloma patients. Blood (2021)
Shwetha H Manjunath, Adam David Cohen, Simon F Lacey, Megan M Davis, Alfred L Garfall, J Joseph Melenhorst, Russell Maxwell, W Tristram Arscott, Amit Maity, Joshua A Jones, John P Plastaras, Edward A Stadtmauer, Bruce L Levine, Carl H June, Michael C Milone, Ima Paydar
The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Edward A Stadtmauer, Joseph A Fraietta, Megan M Davis, Adam David Cohen, Kristy L Weber, Eric Lancaster, Patricia A Mangan, Irina Kulikovskaya, Minnal Gupta, Fang Chen, Lifeng Tian, Vanessa E Gonzalez, Jun Xu, In-Young Jung, J Joseph Melenhorst, Gabriela Plesa, Joanne Shea, Tina Matlawski, Amanda Cervini, Avery L Gaymon, Stephanie Desjardins, Anne Lamontagne, January Salas-Mckee, Andrew D Fesnak, Donald L Siegel, Bruce L Levine, Julie K Jadlowsky, Regina M Young, Anne Chew, Wei-Ting Hwang, Elizabeth O Hexner, Beatriz M Carreno, Christopher L Nobles, Frederic D Bushman, Kevin R Parker, Yanyan Qi, Ansuman T Satpathy, Howard Y Chang, Yangbing Zhao, Simon F Lacey, Carl H June
CRISPR-engineered T cells in patients with refractory cancer. Science (New York, N.Y.) 367 (6481) (2020)
Paul G Richardson, Hans C Lee, Al-Ola Abdallah, Adam David Cohen, Prashant Kapoor, Peter M Voorhees, Axel Hoos, Karrie Wang, January Baron, Trisha Piontek, Julie Byrne, Scott Richmond, Roxanne C Jewell, Joanna Opalinska, Ira Gupta, Sagar Lonial
Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 study. Blood cancer journal 10 (10) (2020)
Alfred L Garfall, Ehren K Dancy, Adam David Cohen, Wei-Ting Hwang, Joseph A Fraietta, Megan M Davis, Bruce L Levine, Don L Siegel, Edward A Stadtmauer, Dan T Vogl, Adam Waxman, Aaron P Rapoport, Michael C Milone, Carl H June, J Joseph Melenhorst
T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma. Blood advances 3 (19) (2020)
Adam David Cohen, Alfred L Garfall, Ahmet Dogan, Simon F Lacey, Chris Martin, Nikoletta Lendvai, Dan T Vogl, Matthew Spear, Alexander M Lesokhin
Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapies. Blood advances 3 (16) (2020)
Sikander Ailawadhi, Rachael Sexton, Suzanne Lentzsch, Muneer H Abidi, Peter M Voorhees, Adam David Cohen, Eric M Rohren, Stephen B Heitner, Kevin Kelly, Niklas J Mackler, David M Baer, Antje Hoering, Brian Durie, Robert Z Orlowski
Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (15) (2020)
Adam David Cohen, Noopur Raje, Jessica A Fowler, Khalid Mezzi, Emma C Scott, Madhav V Dhodapkar
How to Train Your T Cells: Overcoming Immune Dysfunction in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (7) (2019)
Tatiana Pazina, Ashley M James, Kimberly B Colby, Yibin Yang, Andrew P Gale, Amy Jhatakia, Alper Y Kearney, Robert F Graziano, Natalie A Bezman, Michael D Robbins, Adam David Cohen, Kerry S Campbell
Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma. Cancer immunology research 7 (10) (2019)